Advertisement

Brian Callahan's comments on Treylon Burks only adds fuel to the hype fire

BRB about to run through a wall
Leigh Oleszczak
Leigh Oleszczak

Titan Sized

Tennessee Titans v Miami Dolphins / Cooper Neill/GettyImages

The Tennessee Titans are entering a new head coaching era after parting ways with Mike Vrabel in the offseason. It's the Brian Callahan show in Nashville now and the long-time Cincinnati Bengals offensive coordinator is saying all of the right things to pump up the Titan faithful.

The latest pump-up moment from Callahan came when he was talking about Treylon Burks.

"He's really had a fantastic start to the offseason. I've been happy with what he's done. He's done a great job of learning and getting a bunch of different things down and I think he's really stacked a handful of really good days together... I'm really optimistic about him contributing for us and I think he's gone about it the right way."

Brian Callahan hypes up Treylon Burks

Callahan said that Burks is going to do a little bit of everything in 2024, noting that he has the versatility to be used in a variety of ways. He said that it's his job to find the things that Burks excels in and try to highlight those as much as possible.

A first-round pick in 2022, Burks hasn't quite become the weapon that Titans fans were hoping for when they team drafted him. He had 444 receiving yards and one touchdown as a rookie and then only had 221 yards with no touchdowns during the 2023 season.

The hope is that bringing in an offensive-minded guy like Callahan will do wonders for Burks as he enters a critical third year in the league. Hearing that Callahan plans to use Burks in a variety of ways is an exciting thought, let's just hope we see him ball out in 2024 and become a legitimate weapon for Will Levis.

Leigh Oleszczak

Leigh Oleszczak

Leigh has covered the NFL and NFL Draft for 10 years on KC Kingdom, NFL Spin Zone, FanSided, and other sites. She has also covered MLB, college football, and basketball, as well as the TV show Survivor.